Published in Prostate on January 16, 2014
Altered endosome biogenesis in prostate cancer has biomarker potential. Mol Cancer Res (2014) 0.82
Endosomal gene expression: a new indicator for prostate cancer patient prognosis? Oncotarget (2015) 0.77
Food insufficiency is associated with high-risk sexual behavior among women in Botswana and Swaziland. PLoS Med (2007) 4.48
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer. Endocr Relat Cancer (2004) 3.03
Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. Cancer Res (2009) 1.98
Integration of HIV/AIDS services with maternal, neonatal and child health, nutrition, and family planning services. Cochrane Database Syst Rev (2012) 1.84
Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors. Clin Cancer Res (2012) 1.78
Increasing trends in elderly persons' use of nonvitamin, nonmineral dietary supplements and concurrent use of medications. J Am Diet Assoc (2005) 1.76
Exploring the patterns of use and the feasibility of using cellular phones for clinic appointment reminders and adherence messages in an antiretroviral treatment clinic, Durban, South Africa. AIDS Patient Care STDS (2010) 1.73
Dual roles of PARP-1 promote cancer growth and progression. Cancer Discov (2012) 1.63
A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease. Int J Cancer (2012) 1.60
Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors. Cell Cycle (2012) 1.54
Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease. Int J Cancer (2011) 1.46
Lysosomal storage disease: revealing lysosomal function and physiology. Physiology (Bethesda) (2010) 1.42
The contribution of different androgen receptor domains to receptor dimerization and signaling. Mol Endocrinol (2008) 1.32
Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation. Mol Cancer Ther (2007) 1.32
Interventions to improve adherence to antiretroviral therapy in children with HIV infection. Cochrane Database Syst Rev (2011) 1.31
Changes in dietary intake after diagnosis of breast cancer. J Am Diet Assoc (2004) 1.30
Mutational analysis of 105 mucopolysaccharidosis type VI patients. Hum Mutat (2007) 1.30
Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection. Cochrane Database Syst Rev (2011) 1.22
Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha. Cancer Res (2007) 1.20
Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer. FASEB J (2007) 1.19
Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt". Int J Cancer (2010) 1.18
The trans-Golgi network accessory protein p56 promotes long-range movement of GGA/clathrin-containing transport carriers and lysosomal enzyme sorting. Mol Biol Cell (2007) 1.15
Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I. Lancet (2003) 1.13
Intestinal fructose transport and malabsorption in humans. Am J Physiol Gastrointest Liver Physiol (2010) 1.13
Degenerative disc disease treated with combined anterior and posterior arthrodesis and posterior instrumentation. Spine (Phila Pa 1976) (2002) 1.06
Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development. Cancer Epidemiol Biomarkers Prev (2010) 1.05
Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate. Cancer Res (2005) 1.02
Circulating microRNAs: macro-utility as markers of prostate cancer? Endocr Relat Cancer (2012) 1.02
Ex vivo culture of human prostate tissue and drug development. Nat Rev Urol (2013) 1.00
Histone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro. Clin Cancer Res (2003) 0.99
Effect of age on fructose malabsorption in children presenting with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr (2011) 0.99
HIV prevention fatigue among high-risk populations in San Francisco. J Acquir Immune Defic Syndr (2004) 0.97
Disease profile of children under 5 years attending primary health care clinics in a high HIV prevalence setting in South Africa. Trop Med Int Health (2010) 0.97
alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients. J Mol Biol (2004) 0.97
Immunoquantification of alpha-galactosidase: evaluation for the diagnosis of Fabry disease. Clin Chem (2004) 0.96
HIV-infected adolescent mothers and their infants: low coverage of HIV services and high risk of HIV transmission in KwaZulu-Natal, South Africa. PLoS One (2013) 0.94
Fetal growth restriction and the programming of heart growth and cardiac insulin-like growth factor 2 expression in the lamb. J Physiol (2011) 0.93
Developmental changes and fructose absorption in children: effect on malabsorption testing and dietary management. Nutr Rev (2013) 0.93
Laronidase treatment of mucopolysaccharidosis I. BioDrugs (2005) 0.93
Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors. J Steroid Biochem Mol Biol (2008) 0.93
Drosophila 14-3-3ε has a crucial role in anti-microbial peptide secretion and innate immunity. J Cell Sci (2011) 0.92
Hsp90: still a viable target in prostate cancer. Biochim Biophys Acta (2012) 0.92
Shamba Maisha: randomized controlled trial of an agricultural and finance intervention to improve HIV health outcomes. AIDS (2015) 0.91
Development of an assay for the detection of mucopolysaccharidosis type VI patients using dried blood-spots. Clin Chim Acta (2005) 0.90
Monocyte and macrophage killing of helicobacter pylori: relationship to bacterial virulence factors. Helicobacter (2008) 0.90
GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor. Biol Chem (2005) 0.90
Detection of mucopolysaccharidosis type II by measurement of iduronate-2-sulfatase in dried blood spots and plasma samples. Clin Chem (2006) 0.89
GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells. PLoS One (2011) 0.89
Traditional healers for HIV/AIDS prevention and family planning, Kiboga District, Uganda: evaluation of a program to improve practices. AIDS Behav (2005) 0.89
Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors. Oncotarget (2013) 0.88
Molecular pathology and prostate cancer therapeutics: from biology to bedside. J Pathol (2014) 0.88
Dual and triple therapy to prevent mother-to-child transmission of HIV in a resource-limited setting - lessons from a South African programme. S Afr Med J (2011) 0.88
Immune response to enzyme replacement therapy: single epitope control of antigen distribution from circulation. Mol Genet Metab (2002) 0.87
Double disclosure bind: complexities of communicating an HIV diagnosis in the context of unintended pregnancy in Durban, South Africa. AIDS Behav (2014) 0.86
Prediction of neuropathology in mucopolysaccharidosis I patients. Mol Genet Metab (2005) 0.86
SGTA: a new player in the molecular co-chaperone game. Horm Cancer (2013) 0.86
Neonatal gene therapy with a gamma retroviral vector in mucopolysaccharidosis VI cats. Mol Ther (2012) 0.85
Challenges faced by health-care providers offering infant-feeding counseling to HIV-positive women in sub-Saharan Africa: a review of current research. AIDS Care (2014) 0.85
The dynamic and static modification of the epigenome by hormones: a role in the developmental origin of hormone related cancers. Biochim Biophys Acta (2009) 0.84
An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity. Endocr Relat Cancer (2012) 0.84
Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells. Mol Cell Endocrinol (2011) 0.83
Ski-interacting protein (SKIP) interacts with androgen receptor in the nucleus and modulates androgen-dependent transcription. BMC Biochem (2013) 0.83
Uncoupling of hormone-dependence from chaperone-dependence in the L701H mutation of the androgen receptor. Mol Cell Endocrinol (2007) 0.82
Subdomain structure of the co-chaperone SGTA and activity of its androgen receptor client. J Mol Endocrinol (2012) 0.82
Immunochemistry of lysosomal storage disorders. Clin Chem (2006) 0.82
Multiple nuclear receptor signaling pathways mediate the actions of synthetic progestins in target cells. Mol Cell Endocrinol (2011) 0.81
Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): a Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine 4-sulfatase at multiple points in the vacuolar network. Biochemistry (2002) 0.81
Alteration of cardiac glucose metabolism in association to low birth weight: experimental evidence in lambs with left ventricular hypertrophy. Metabolism (2013) 0.81
Iduronate-2-sulphatase protein detection in plasma from mucopolysaccharidosis type II patients. Mol Genet Metab (2004) 0.81
Remodeling of the lymphatic vasculature during mouse mammary gland morphogenesis is mediated via epithelial-derived lymphangiogenic stimuli. Am J Pathol (2012) 0.80
Activation of IGF-2R stimulates cardiomyocyte hypertrophy in the late gestation sheep fetus. J Physiol (2012) 0.80
Helicobacter pylori phagosome maturation in primary human macrophages. Gut Pathog (2011) 0.80
The alpha-L-iduronidase mutations R89Q and R89W result in an attenuated mucopolysaccharidosis type I clinical presentation. Biochim Biophys Acta (2003) 0.80
Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferation. Int J Cancer (2013) 0.79
IGF-2R-mediated signaling results in hypertrophy of cultured cardiomyocytes from fetal sheep. Biol Reprod (2012) 0.79
Innate immunity and exocytosis of antimicrobial peptides. Commun Integr Biol (2012) 0.79
Immunochemical analysis of CD107a (LAMP-1). Cell Immunol (2005) 0.79
Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers. Prostate (2012) 0.79
Mass spectrometric quantification of glycogen to assess primary substrate accumulation in the Pompe mouse. Anal Biochem (2011) 0.78
A role for altered phagosome maturation in the long-term persistence of Helicobacter pylori infection. Am J Physiol Gastrointest Liver Physiol (2012) 0.78
Identification of prostate cancer-associated microRNAs in circulation using a mouse model of disease. Methods Mol Biol (2013) 0.78
Aminoglycoside-Induced Premature Stop Codon Read-Through of Mucopolysaccharidosis Type I Patient Q70X and W402X Mutations in Cultured Cells. JIMD Rep (2013) 0.78
Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapy. Mol Genet Metab (2006) 0.77
N-acetylgalactosamine-6-sulfatase protein detection in MPS IVA patient and unaffected control samples. Clin Chim Acta (2006) 0.77
Finding the place of histone deacetylase inhibitors in prostate cancer therapy. Expert Rev Clin Pharmacol (2009) 0.77
Getting into the fold. Nat Chem Biol (2007) 0.77
Stabilising normal and mis-sense variant alpha-glucosidase. FEBS Lett (2006) 0.76
Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo. Menopause (2014) 0.76
Is small-bowel bacterial overgrowth an underdiagnosed disorder in children with gastrointestinal symptoms? J Pediatr Gastroenterol Nutr (2011) 0.76
Early origins of heart disease: low birth weight and the role of the insulin-like growth factor system in cardiac hypertrophy. Clin Exp Pharmacol Physiol (2012) 0.76
Common antigenicity for two glycosidases. FEBS Lett (2005) 0.75